Revolutionising healthcare: Bradley Bostic on lab data and AI at JP Morgan 2025
An important lesson of the AI revolution has been that AI is only as good as the data it’s trained on. So finding and investing in high-quality sources of healthcare data has never been more important than it is right now.
At the JP Morgan Healthcare Conference in January, pharmaphorum editor-in-chief Jonah Comstock caught up with Bradley Bostic, the co-founder, CEO, president, and chairman of h1c to talk about one such data source: lab data.
In a wide-ranging conversation, they discuss a growing awakening to the importance and power of lab data; the value of that data for patients, payers, caregivers, and pharma; and the value of bringing those stakeholders together around the patient.
They also cover a lot more ground, from reimbursement trends to the prospects for AI in healthcare. Check out the full interview below.
